33 Swiss Pharmaceuticals & Biotech Stocks - Potentially Undervalued Companies - Investing Ideas

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
TECN Tecan Group	CHF322.60	-6.8%	-20.8%	CHF4.1b	CHF395.57	PE31.3x	E9.2%	0.9%
BIIB Biogen	US$222.00	0%	0%	US$28.3b	US$332.61	PE24.3x	E18.2%	n/a
MER Merck KGaA	€154.11	0%	n/a	€63.5b	€192.11	PE22.5x	E10.0%	1.5%
NOVN Novartis	CHF87.36	1.0%	-2.4%	CHF191.3b	CHF96.71	PE24.5x	E9.5%	3.8%
SDZ Sandoz Group	CHF31.02	10.2%	n/a	CHF13.3b	CHF35.13	PE189.9x	E29.7%	1.4%
TEVA Teva Pharmaceutical Industries	US$7.85	0%	0%	US$14.6b	US$9.59	PB1.9x	E32.1%	0%
1102657 GSK	UK£26.12	0%	-2.8%	UK£70.6b	UK£34.09	PE13.8x	E8.9%	5.7%
ROG Roche Holding	CHF225.80	0.3%	-19.6%	CHF182.0b	CHF281.06	PE15.7x	E8.2%	4.3%
GXI Gerresheimer	€75.60	0%	0%	€3.5b	€99.05	PE29.9x	E20.8%	1.2%
RO Roche Holding	CHF244.20	0.7%	-19.2%	CHF182.0b	CHF303.96	PE15.7x	E8.2%	4.3%
ESF Eurofins Scientific	€505.00	0%	0%	€11.7b	€550.95	PE20.1x	E4.7%	1.7%
943981 Johnson & Johnson	US$135.76	0.07%	-6.7%	US$356.4b	US$158.05	PE18.7x	E5.1%	3.3%
EVT Evotec	€27.76	0%	0%	€2.4b	€51.47	PS3x	E57.9%	n/a
BMY Bristol-Myers Squibb	US$54.24	0%	0%	US$99.2b	US$62.03	PE12.4x	E7.8%	4.9%
JCARE Joincare Pharmaceutical Group IndustryLtd	CN¥8.00	0%	-54.5%	CN¥22.0b	CN¥9.73	PE15.2x	E10.3%	1.5%
2HQ Tilray Brands	US$46.28	0%	0%	US$1.3b	US$63.90	PS1.8x	E86.1%	n/a
MER Merck KGaA	€228.30	0%	n/a	€64.2b	€281.32	PE22.7x	E10.0%	1.5%
VRX Bausch Health Companies	US$24.11	0%	0%	US$3.2b	US$29.14	PE-5.2x	E93.4%	n/a
NOVNEE Novartis	CHF87.53	1.0%	-2.3%	CHF191.3b	CHF96.90	PE24.5x	E9.5%	3.8%
J7Z Jazz Pharmaceuticals	US$104.98	0%	n/a	US$6.9b	US$179.72	PE16.5x	E17.4%	n/a
935700 Gilead Sciences	US$68.48	0%	10.5%	US$94.1b	US$82.84	PE17.2x	E7.8%	4.0%
QIA Qiagen	US$50.36	0%	0%	US$8.9b	US$61.99	PE26.7x	E11.3%	n/a
OBSN ObsEva	CHF0.005	-10.7%	-94.1%	CHF585.9k	n/a	PE0.08x	n/a	n/a
907582 Amgen	US$226.36	0%	n/a	US$145.8b	US$229.35	PE19.3x	E5.7%	3.1%

Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies